Everything Is Changing! Should You Dump Lockheed Martin Corporation (LMT), WellCare Health Plans, Inc. (WCG)?

14 analysts out of 21 Wall Street brokerage firms rate Lockheed Martin Corporation (NYSE:LMT) as a Buy, while 0 see it as a Sell. The rest 7 describe it as a Hold. LMT stock traded higher to an intra-day high of $304.46. At one point in session, its potential discontinued and the price was down to lows at $298.32. Analysts have set LMT’s consensus price at $342.61, effectively giving it a 14.77% projection on returns. Should the projected estimates be met, then the stock will likely hit its highest price at $405 (up 35.67% from current price levels).

It is expected that in Mar 2019 quarter LMT will have an EPS of $4.3, suggesting a 6.97% growth. For Jun 2019 is projected at $4.77. It means that there could be a 10.67% growth in the quarter. Yearly earnings are expected to rise by 8.8% to about $19.42. As for the coming year, growth will be about 25.95%, lifting earnings to $24.46. RSI after the last trading period was 46.7. LMT recorded a change of -1.49% over the past week and returned 2.18% over the last three months while the LMT stock’s monthly performance revealed a shift in price of -1.84%. The year to date (YTD) performance stands at 14%, and the bi-yearly performance specified an activity trend of -7.36% while the shares have moved -10.48% for the past 12 months.

Lockheed Martin Corporation (LMT) currently trades at $298.51, which is lower by -1.63% its previous price. It has a total of 284.5 million outstanding shares, with an ATR of around 4.73. The company’s stock volume dropped to 1.17 million, worse than 1.38 million that represents its 50-day average. A 5-day decrease of about -1.49% in its price means LMT is now 14% higher on year-to-date. The shares have surrendered $43161.49 since its $361.99 52-week high price recorded on 24th of April 2018. Overall, it has seen a growth rate of -10.48 over the last 12 months. The current price per share is $57.33 above the 52 week low of $241.18 set on 26th of December 2018.

Lockheed Martin Corporation (NYSE:LMT)’s EPS was $4.39 as reported for the December quarter. In comparison, the same quarter a year ago had an EPS of $3.87. That means that its growth in general now stands at 13%. Therefore, a prediction of $4.4 given by the analysts brought a negative surprise of 0%. LMT Dec 19 quarter revenue was $14.41 billion, compared to $15.14 billion recorded in same quarter last year, giving it a -5% growth rate. The company’s $-0.73 billion revenue decline that quarter surprised Wall Street and investors will need to consider this as they assess the stock.

WellCare Health Plans, Inc. (NYSE:WCG) shares depreciated -2.17% over the last trading period, taking overall 5-day performance up to 2.39%. The general public currently hold control of a total of 49.65 million shares, which is the number publicly available for trading. The total of shares that it has issued to investors is 49.99 million. The company’s management holds a total of 0.5%, while institutional investors hold about 0% of the remaining shares. WCG share price finished last trade -6.86% below its 20 day simple moving average and its downbeat gap from 200 day simple moving average is -9.61%, while closing the session with -7.24% distance from 50 day simple moving average.

WCG’s beta is 1.25; meaning investors could reap higher returns, although it also poses higher risks. The company allocated $9.46 per share from its yearly profit to its outstanding shares. Its last reported revenue is $6.07 billion, which was 40% versus $4.35 billion in the corresponding quarter last year. The EPS for Dec 19 quarter came in at $1.63 compared to $0.32 in the year-ago quarter and had represented 409% year-over-year earnings per share growth.

Estimated quarterly earnings for WellCare Health Plans, Inc. (NYSE:WCG) are around $3.19 per share in three months through March with $4.17 also the estimate for June quarter of the fiscal year. It means the growth is estimated at 29.15% and 13.01%, respectively. Analysts estimate full-year growth to be 23.21%, the target being $13.59 a share. The upcoming year will see an increase in growth by percentage to 21.27%, more likely to see it hit the $16.48 per share. The firm’s current profit margin over the past 12 months is 2.2%.